loading

Galectin Therapeutics Inc (GALT) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
41.43%
4.625
7.897 12.43 9.066 11.29
Operating Income/Loss
41.43%
-4.625
-7.897 -12.43 -9.066 -11.29
Nonoperating Income/Loss
67.01%
-2.896
-1.734 0.461 -2.154 -1.08
Income/Loss From Continuing Operations Before Tax
21.91%
-7.521
-9.631 -11.97 -11.22 -12.37
Income/Loss From Continuing Operations After Tax
21.91%
-7.521
-9.631 -11.97 -11.22 -12.37
Net Income/Loss
21.91%
-7.521
-9.631 -11.97 -11.22 -12.37
Preferred Stock Dividends And Other Adjustments
342.31%
0.063
-0.026 0.063 0.018 0.064
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.38%
63.45
63.20 0.146 62.28 62.23
Diluted Average Shares
0.38%
63.45
63.20 0.146 62.28 62.23
Basic Earnings Per Share
20.00%
-0.12
-0.15 -0.19 -0.18 -0.20
Diluted Earnings Per Share
20.00%
-0.12
-0.15 -0.19 -0.18 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
342.31%
0.063
-0.026 0.063 0.018 0.064
$86.19
price up icon 0.43%
$27.05
price up icon 4.33%
$23.78
price down icon 0.78%
$100.55
price down icon 0.08%
$145.00
price down icon 0.18%
biotechnology ONC
$339.24
price up icon 2.07%
자본화:     |  볼륨(24시간):